Tickner, T. R., Cramp, D. G., Foo, A. Y., Johnson, A. J., Bateman, S. M., Pidgeon, J., Spiro, S. G., Clarke, S. W., and Wills, M. R. (1977) . Thorax, 32, [182] [183] [184] . Metabolic response to intravenous salbutamol therapy in acute asthma. In patients suffering from an acute attack of asthma the effects of salbutamol infusion (10Oug/min) on their plasma concentrations of non-esterified fatty acids (NEFA), triglyceride, insulin, and glucose were compared with those in a group of asthmatics not requiring infusion. Salbutamol was found significantly to increase the plasma concentrations of glucose and insulin while having little effect on NEFA or triglyceride. However, NEFA concentrations were found to be significantly increased in patients with an acute attack of asthma at the time of their admission to hospital. This increase is attributed to the stress of the asthmatic attack itself.
Increased plasma non-esterified fatty acid (NEFA) concentrations have been associated with myocardial arrhythmias (Oliver, 1972) . Such increases have been reported to follow the intravenous injection in normal subjects of the /39 sympathomimetic drug salbutamol (Goldberg et al., 1975) . These findings led to the suggestion that this drug could be dangerous when used for asthmatic patients already subjected to the hypoxia and tachycardia of the disease itself (British Medical Journal, 1975; Goldberg et al., 1975 The patients studied and the severity of their asthma on admission are summarised in Table 1 . Eight of the control group and five of the infusion group were taking oral prednisone before admission. Eighteen subjects in the control group and 15 in the infusion group were on regular salbutamol medication. On admission to hospital corticosteroids were prescribed for all subjects except three of the control group. In the 4 h following the completion of the initial regimen neither group received any bronchodilator therapy additional to the salbutamol given to the infusion group.
After collection, the blood samples were centri-Metabolic response to intravenous salbutamol therapy in acute asthma 
Results
The 20 subjects in the control group and the 16 allocated to salbutamol were all matched for age, sex, and height. Their arterial blood gas values. peak expiratory flow rate (PEFR), heart rate, and respiratory rate on admission were also similar (Table 1) . After the initial standard regimen those subjects considered to have improved sufficiently not to require an intravenous infusion of salbutamol (the control group) had increased their PEFR from 111 /min (SEM± 102) to 220 1 /min (SEM ±1 4 3), while those judged to have responded poorly (the salbutamol group) showed a smaller increase in PEFR, 95 1/min (+±82) to 138 1/min (+9 0).
On admission mean plasma NEFA were elevated from the normal laboratory range (<600 Itmol/1) in both groups of patients and were significantly increased when compared with fasting values obtained after resolution of the asthma attack (Table 2) . No further increase in NEFA occurred during the salbutamol infusion, nor did plasma triglyceride concentration alter (Fig. 1) . Following initial therapy the plasma insulin and glucose concentrations rose, the increase becoming significant for both variables only in the control Journal, 1975; Goldberg i et al., 1975) , are unfounded when the drug is used in the treatment of acute asthma. Nevertheless, plasma NEFA concentration was significantly higher during the asthmatic attack than in the same patients when used as their own fasting controls. Since no difference was noted between ad-* ,mission and convalescent plasma concentrations of insulin, glucose, or triglyceride, it is unlikely * | that dietary differences can explain those findings. Furthermore, the convalescent patients were receiving doses of steroids and bronchodilators equivalent to or greater than those before admission, so that changes in therapy do not explain the differences. Therefore, it appears that the in- 
